Intentar ORO - Gratis

India, critical player in global laboratory equipment scene

Chronicle Pharmabiz

|

October 16, 2025

THE vibrant Indian laboratory equipment and analytical instruments market is poised for significant growth, fuelled by rising investments in research and development (R&D), contract research projects and increasing demand for advanced laboratory techniques.

- By Nandita Vijayasimha, Bengaluru

India, critical player in global laboratory equipment scene

The sector is further propelled by innovation and strategic collaborations. The rising startup activity and increased foreign direct investment in lab equipment and analytical instrumentation, position India as a critical player in the space.

According to a market report, laboratory equipment services market size is estimated to reach $22.1 billion by 2027, growing at a CAGR of 11.1 per cent during the forecast period 2022-2027 with the Asia-Pacific region expected to be the highest contributor to this growth.

The big names in the lab market in India investing in R&D include Agilent Technologies; Thermo Fisher Scientific Inc.; Waters Corporation; Danaher Corporation; Merck Eppendorf AG; PerkinElmer Inc; Pace Analytical Services Inc.

The age of automation

In an age of Industry 4.0 automation, robotics, Internet of Things (IoT), Artificial Intelligence (AI), Machine Learning (ML) and advanced imaging techniques are signalling a shift in investment priorities. Advances in imaging technologies, like high-resolution microscopy and imaging software allow for detailed and accurate analysis in research and diagnostics. 3D Printing technology helps develop custom lab equipment and prototypes, allowing for rapid development and testing of new devices.

No doubt technology infusion is streamlining laboratory processes, increasing efficiency, and decreasing human error in sample analysis and data collection. AI and ML are enabling advanced data analysis, predictive maintenance, and personalized medicine, allowing for more accurate and faster results. Further, IoT-enabled devices are improving connectivity between lab instruments, facilitating real-time monitoring and data sharing, which speeds up decision-making.

MÁS HISTORIAS DE Chronicle Pharmabiz

Chronicle Pharmabiz

US FDA fortifies alliance with Telangana DCA

A high-level delegation from the US FDA concluded a significant meeting with the DCA in Telangana, two days ago, at the DCA office in Hyderabad.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

India exploring possibilities to expand WHO standards for Indian medicines

INDIA is looking at possibilities to expand the World Health Organisation (WHO) global benchmarking standards for medicines, in order to unify and strengthen the drug regulatory mechanism for safety, quality and efficacy of medicines sold in the country.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

Eli Lilly gets US FDA approval for Jaypirca

Eli Lilly and Company announced that the US Food and Drug Administration (FDA) has granted approval to Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for the treatment of adults with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL) who have previously been treated with a covalent Bruton tyrosine kinase (BTK) inhibitor.

time to read

1 mins

December 11, 2025

Chronicle Pharmabiz

Haryana DCA focuses on quality overhaul

THE Haryana drug control administration (DCA) is undertaking a major organizational overhaul focused on quality system upgrades and regulatory capacity building, particularly in response to the revised Schedule M norms.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

DoC seeks inputs on trade issues faced with Japan

THE Department of Commerce (DoC), under the Union Commerce Ministry, has sought inputs from the industry on specific issues being faced in pharma trade with Japan.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

AIOCD asks traders to strictly comply with ban on 35 FDCs

THE All India Organisation of Chemists and Druggists (AIOCD) has issued an urgent internal circular to all its state and Union territory trade bodies, demanding immediate and strict compliance with the ban on 35 fixed dose combinations (FDCs).

time to read

3 mins

December 11, 2025

Chronicle Pharmabiz

US FDA approves Bristol Myers Squibb's Breyanzi

Bristol Myers Squibb announced that the US Food and Drug Administration (FDA) has granted approval of Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) who have received at least two prior lines of systemic therapy.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

CN Water presents AQU@Sense MB

CN Water is now combining core water-system expertise with digital assurance has launched AQU@Sense which delivers microbial test results in under 30 minutes, replacing traditional 5 to 7 days culture based methods.

time to read

1 min

December 11, 2025

Chronicle Pharmabiz

Pharma logistics sees policy push as key catalyst for growth

INDIAN pharma's logistics sector is getting major boost from emerging policy support.

time to read

2 mins

December 11, 2025

Chronicle Pharmabiz

Lack of financial aid, expertise mar MSME prospects to meet revised Sch M deadline

INDUSTRY experts have raised alarm that lack of financial assistance and guidance on technical expertise have marred pharma MSMEs’ prospects to comply with revised Schedule M guidelines of December 31, 2025.

time to read

2 mins

December 11, 2025

Listen

Translate

Share

-
+

Change font size